Salisch NC, Stephenson KE, Williams K, Cox F, et al. A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine. Ann Intern Med 2021 Feb 16. doi: 10.7326/M20-5306.
PMID: 33587687